COVID-19 À¯Çà ½Ã±âÀÇ ¼ºÀÎ ¿°Áõ¼º ÀåÁúȯ ÀÓ»ó Áø·áÁöħ: Àü¹®°¡ ÇÕÀÇ ±Ç°í¹®
KASID Guidance for Clinical Practice Management of Adult Inflammatory Bowel Disease during the COVID-19 Pandemic: Expert Consensus Statement
´ëÇѼÒȱâÇÐȸÁö 2021³â 78±Ç 2È£ p.105 ~ p.116
¹Ú¿ëÀº(Park Yong-Eun) - Inje University College of Medicine Haeundae Paik Hospital Department of Internal Medicine
ÀÌÀ¯Áø(Lee Yoo-Jin) - Keimyung University School of Medicine Department of Internal Medicine
ÀåÁö¿µ(Chang Ji-Young) - Ewha Womans University College of Medicine Ewha Womans University Seoul Hospital Department of Health Promotion Medicine
¼ÛÇöÁÖ(Song Hyun-Joo) - Jeju National University College of Medicine Department of Internal Medicine
±è´öȯ(Kim Duck-Hwan) - CHA University CHA Bundang Medical Center Digestive Disease Center
¾ç¿µÁÖ(Yang Young-Joo) - Hallym University College of Medicine Hallym University Chuncheon Sacred Heart Hospital Department of Internal Medicine
±èº´Ã¢(Kim Byung-Chang) - National Cancer Center Center for Colorectal Cancer
ÀÌÀç°ï(Lee Jae-Gon) - Hallym University College of Medicine Hallym University Dongtan Sacred Heart Hospital Department of Internal Medicine
¾çÈñÂù(Yang Hee-Chan) - Jeonbuk National University Medical School Department of Internal Medicine
Ãֹ̿µ(Choi Mi-Young) - National Evidence-Based Healthcare Collaborating Agency
±è¼ºÀº(Kim Seong-Eun) - Ewha Womans University College of Medicine Ewha Womans University Mokdong Hospital Department of Internal Medicine
¸í½ÂÀç(Myung Seung-Jae) - University of Ulsan College of Medicine Asan Medical Center Department of Gastroenterology
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has reduced the ability to prevent or control chronic disease due to the concerns about safety in accessing health care. Inflammatory bowel disease (IBD) is a chronic condition requiring long- term sustained treatment, which is difficult in the current panedemic situation. The Korean Association for the Study of Intestinal Diseases (KASID) has developed an expert consensus statement on the clinical practice management of adult inflammatory bowel disease during the COVID-19 pandemic. This expert consensus statement is based on guidelines and clinical reports from several countries around the world. It provides recommendations to deal with the risk of COVID-19 and medication use in IBD patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and emphasizes the importance of right treatment approach to avoid worsening of the disease condition in IBD patients.
Å°¿öµå
SARS-CoV-2, COVID-19, Inflammatory bowel diseases, Disease management
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)
This article provides recommendations to deal with the risk of COVID-19 and medication use in IBD patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and emphasizes the importance of right treatment approach to avoid worsening of the disease condition in IBD patients.